Search Results

Rivals Emerge to Ozempic and Zepbound—but With a Lag.

• Authors : Wainer, David (AUTHOR)

Subjects: SEMAGLUTIDE; BIOPHARMACEUTICS

• Source: Wall Street Journal - Online Edition. 7/20/2024, pN.PAG-N.PAG. 1p.

Record details

Requiem for Eiger Biopharmaceuticals.

Subjects: BIOPHARMACEUTICS; LIFE sciences

• Source: Wall Street Journal - Online Edition. 4/8/2024, pN.PAG-N.PAG. 1p.

Record details

CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal.

• Authors : Kellaher, Colin (AUTHOR)

Subjects: *FINANCIAL performance; BIOPHARMACEUTICS

• Source: Wall Street Journal - Online Edition. 2/13/2024, pN.PAG-N.PAG. 1p.

Record details

Sarepta Gets Boost From Early Trial Results on Muscular Dystrophy Treatment.

• Authors : Al-Muslim, Aisha

Subjects: BIOPHARMACEUTICS; TREATMENT of Duchenne muscular dystrophy; TREATMENT effectivenessSAREPTA Therapeutics Inc.

• Source: Wall Street Journal - Online Edition. 6/20/2018, p1. 1p.

Record details

Biogen Announces CEO Search, Lifts Guidance.

• Authors : Beilfuss, Lisa

Subjects: *STOCK repurchasing; *INVESTORS; BIOPHARMACEUTICSBIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIBSCANGOS, George

• Source: Wall Street Journal - Online Edition. 7/22/2016, p1. 1p.

Record details

Biosimilars Are Complex, Costly to Produce.

Subjects: *PHARMACEUTICAL industry; BIOPHARMACEUTICS; DRUG factories

• Source: Wall Street Journal - Online Edition. 5/27/2016, p1. 1p.

Record details

A $3 Million Gene-Therapy Maker at a Bargain Price.

• Authors : Wainer, David

Subjects: PRICES; SALES statistics; FINANCIAL performanceNORTH America

• Source: Wall Street Journal - Online Edition. 8/20/2024, pN.PAG-N.PAG. 1p.

Record details

$19 Billion in a Week: AbbVie Makes Two Big Bets.

• Authors : Wainer, David (AUTHOR)

Subjects: SALES statistics; FINANCIAL performance; LIFE sciences

• Source: Wall Street Journal - Online Edition. 12/9/2023, pN.PAG-N.PAG. 1p.

Record details

Servier Treatment Breakthrough Cited for an Intractable Brain Cancer.

• Authors : Abbott, Brianna (AUTHOR)

Subjects: BRAIN cancer; ANTINEOPLASTIC agents; DRUGS

• Source: Wall Street Journal - Online Edition. 6/5/2023, pN.PAG-N.PAG. 1p.

Record details

Investors' Best Friend in 2022: The Dogs of the Dow.

• Authors : Singh, Hardika (AUTHOR)

Subjects: AMGEN Inc.; DOGS; BEST friends

• Source: Wall Street Journal - Online Edition. 1/6/2023, pN.PAG-N.PAG. 1p.

Record details